Shiksha Nation
Skip to content

Intradermal injection

  • 2 min read
  • 5 chapters

Related on Lably

Through Allergy, Syringe and Litre

Vaccine dose sparing

For vaccination many clinical studies have proven efficacy of ID administration over subcutaneous (SC), intramuscular (IM) or other routes of administration. Since the COVID19 pandemic (2020) EMA and FDA promote the use of ID route of administration in case of possible vaccine shortage, for example during the Monkeypox outbreak in 2022 where 1/5th intradermal (fractional) dosing was advised, due to a risk of vaccine shortage.

Sign up free to read the rest

4 more chapters are free with a Lably account.

Already have an account?

More in Health